(Q37887372)

24 August 2017

1 reference

title

Group A streptococcal tonsillopharyngitis: cost-effective diagnosis and treatment (English)

1 reference

24 August 2017

0 references

Pichichero ME

1

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 March 1995

1 reference

Annals of Emergency Medicine

24 August 2017

published in

1 reference

24 August 2017

volume

25

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

390-403

1 reference

Current problems in managing streptococcal pharyngitis

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Management of streptococcal pharyngitis reconsidered.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Treatment of streptococcal pharyngotonsillitis: reports of penicillin's demise are premature

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Erythromycin therapy for group A streptococcal pharyngitis. Results of a comparative study of the estolate and ethylsuccinate formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Comparative efficacy and toxicity of roxithromycin and erythromycin ethylsuccinate in the treatment of streptococcal pharyngitis in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Comparison of the clinical and bacteriological efficacy of clarithromycin and erythromycin in the treatment of streptococcal pharyngitis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

The rising incidence of penicillin treatment failures in group A streptococcal tonsillopharyngitis: an emerging role for the cephalosporins?

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Alternatives to penicillin in the management of group A streptococcal pharyngitis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Explanations and therapies for penicillin failure in streptococcal pharyngitis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Viral and bacterial organisms associated with acute pharyngitis in a school-aged population

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Pharyngitis in adults: the presence and coexistence of viruses and bacterial organisms

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Pharyngitis associated with herpes simplex virus in college students.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Clinical spectrum of pharyngeal gonococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Tonsillitis and rash associated with Corynebacterium haemolyticum

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Corynebacterium hemolyticum as a cause of pharyngitis and scarlatiniform rash in young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Arcanobacterium haemolyticum in children with presumed streptococcal pharyngotonsillitis or scarlet fever

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Role of Chlamydia trachomatis in acute pharyngitis in young adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Chlamydia pneumoniae strain TWAR, Mycoplasma pneumoniae, and viral infections in acute respiratory disease in a university student health clinic population

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Association of group C beta-hemolytic streptococci with endemic pharyngitis among college students

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Do the beta-hemolytic non-group A streptococci cause pharyngitis?

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Nonstreptococcal pharyngitis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Rapid diagnosis of adenoviral tonsillitis: A prospective clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

The accuracy of diagnosis of beta streptococcal infections on clinical grounds

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Applicability of a scoring system in the diagnosis of streptococcal pharyngitis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Comparative reliability of clinical, culture, and antigen detection methods for the diagnosis of group A beta-hemolytic streptococcal tonsillopharyngitis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

The rapid identification of group A beta-hemolytic streptococci in the upper respiratory tract. Current status

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Comparison of throat cultures and rapid strep tests for diagnosis of streptococcal pharyngitis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Throat cultures and rapid tests for diagnosis of group A streptococcal pharyngitis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Suitability of throat culture procedures for detection of group A streptococci and as reference standards for evaluation of streptococcal antigen detection kits.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Comparison of a latex agglutination test and four culture methods for identification of group A streptococci in a pediatric office laboratory

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

The diagnosis of group A, beta-hemolytic streptococcal pharyngitis in the office setting. Rapid latex test vs throat culture

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Evaluation of the throat culture as a follow-up for an initially negative enzyme immunosorbent assay rapid streptococcal antigen detection test

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Adult and pediatric pharyngitis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

An Analysis of the Cost-Effectiveness of Pharyngitis Management and Acute Rheumatic Fever Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Comparative costs of diagnosis and treatment in acute pharyngitis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

The comparative cost-effectiveness of statistical decision rules and experienced physicians in pharyngitis management.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Prevention of rheumatic fever; treatment of the preceding streptococcic infection

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

The effect of penicillin prophylaxis on streptococcal disease rates and the carrier state

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Treatment of beta hemolytic streptococcic infections in the home; relative value of available methods

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Penicillin V for group A streptococcal pharyngotonsillitis. A randomized trial of seven vs ten days' therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Resistance to Erythromycin in Group A Streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

A controlled trial of erythromycin in adults with nonstreptococcal pharyngitis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Efficacy of cefuroxime axetil suspension compared with that of penicillin V suspension in children with group A streptococcal pharyngitis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Comparative study of the effectiveness of cefixime and penicillin V for the treatment of streptococcal pharyngitis in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Cefprozil versus penicillin V in treatment of streptococcal tonsillopharyngitis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Loracarbef (LY163892) vs. penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Cefpodoxime proxetil vs. penicillin V in pediatric streptococcal pharyngitis/tonsillitis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Lack of influence of beta-lactamase-producing flora on recovery of group A streptococci after treatment of acute pharyngitis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Eradication of group A streptococci from the upper respiratory tract by amoxicillin with clavulanate after oral penicillin V treatment failure

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Treatment of patients with acute recurrent tonsillitis due to group A beta-haemolytic streptococci: a prospective randomized study comparing penicillin and amoxycillin/clavulanate potassium

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

The treatment of the carrier state of group A beta-hemolytic streptococci with clindamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Penicillin V and rifampin for the treatment of group A streptococcal pharyngitis: a randomized trial of 10 days penicillin vs 10 days penicillin with rifampin during the final 4 days of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Penicillin plus rifampin eradicates pharyngeal carriage of group A streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Five day treatment of pharyngotonsillitis with cefpodoxime proxetil

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Effective short-course treatment of acute group A beta-hemolytic streptococcal tonsillopharyngitis. Ten days of penicillin V vs 5 days or 10 days of cefpodoxime therapy in children

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

The effect of prescribed daily dose frequency on patient medication compliance

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Strategies to improve compliance with therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

PENICILLIN IN STREPTOCOCCAL INFECTIONS; TOTAL DOSE AND FREQUENCY OF ADMINISTRATION

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

A clinical experience with cefadroxil in upper respiratory tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

A multicenter, randomized, single-blind evaluation of cefuroxime axetil and phenoxymethyl penicillin in the treatment of streptococcal pharyngitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Once daily therapy for streptococcal pharyngitis with cefadroxil

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Randomized, single-blind evaluation of cefadroxil and phenoxymethyl penicillin in the treatment of streptococcal pharyngitis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Clinical comparison of once-daily cefadroxil and thrice-daily cefaclor in the treatment of streptococcal pharyngitis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Cefadroxil versus penicillin in the treatment of streptococcal tonsillopharyngitis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Streptococcal pharyngitis. Placebo-controlled double-blind evaluation of clinical response to penicillin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Effect of types of treatment on development of antistreptolysin in patients with scarlet fever

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

THE COMPARATIVE EFFECTS OF CONTINUOUS AND INTERMITTENT PENICILLIN THERAPY ON THE FORMATION OF ANTISTREPTOLYSIN IN HEMOLYTIC STREPTOCOCCAL PHARYNGITIS.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Streptococcal bacteriostatic antibody in patients treated with penicillin.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Studies on the prevention of rheumatic fever; the effect of time of initiation of treatment of streptococcal infections on the immune response of the host

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Type-specific streptococcal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Penicillin treatment and immunity to scarlatina

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

The prevention of type specific immunity to streptococcal infections due to the therapeutic use of penicillin. Occurrence of second attacks due to the same type of group A hemolytic streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Penicillin in the prevention of scarlet fever

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Lack of impact of early antibiotic therapy for streptococcal pharyngitis on recurrence rates

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Penicillin tolerance in beta-streptococci isolated from patients with tonsillitis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

An epidemic of penicillin-tolerant group A streptococcal pharyngitis in children living in a closed community: mass treatment with erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Evidence suggesting importance of role of interbacterial inhibition in maintaining balance of normal flora

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Bacterial Interference. I. Its Occurrence among the Respiratory Tract Flora and Characterization of Inhibition of Group A Streptococci by Viridans Streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Bacterial interference. II. Role of the normal throat flora in prevention of colonization by group A Streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Bacterial Interference IV. Epidemiological Determinants of the Antagonistic Activity of the Normal Throat Flora Against Group A Streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Viridins, Bacteriocins of Alpha-Hemolytic Streptococci: Isolation, Characterization, and Partial Purification

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Factors affecting production of the group A streptococcus bacteriocin SA-FF22

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Evaluation of bacterial interference and beta-lactamase production in management of experimental infection with group A beta-hemolytic streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Evaluation of beta-lactamase activity and microbial interference in treatment failures of acute streptococcal tonsillitis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Interfering alpha-streptococci as a protection against recurrent streptococcal tonsillitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Alpha-streptococci as supplementary treatment of recurrent streptococcal tonsillitis: a randomized placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Diagnosis of Streptococcal Pharyngitis: Differentiation of Active Infection from the Carrier State in the Symptomatic Child

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Efficacy of benzathine penicillin G in group A streptococcal pharyngitis: reevaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970300-4

7 January 2021

10.1016/S0196-0644(95)70300-4

Identifiers

DOI

1 reference

24 August 2017

1 reference